insights_auto
Why is GANX down 5.41%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.05
arrow_downward
-5.41%(-0.060) 1D
US$1.07
arrow_upward
+1.90% (+0.020)bedtimeAfter hours
Closed: ኖቬም 19, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.12
High
US$1.14
Low
US$1.03
Mkt. cap
46.75 ሚ
Avg. vol.
684.23 ሺ
Volume
0.00
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.12
High
US$1.14
Low
US$1.03
Mkt. cap
46.75 ሚ
Avg. vol.
684.23 ሺ
Volume
0.00
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
Yahoo Finance
·
ከ31 ደቂቃዎች በፊት
Stock Market: Will S&P 500 Open Up or Down Today?
Adam Feldman | Substack
·
ከ12 ሰዓቶች በፊት
Inside the Federal Litigation of Five S&P 500 Giants
The Motley Fool
·
ከ7 ሰዓቶች በፊት
The Semiconductor ETF Is on Track to Beat the S&P 500 for a 4th Straight Year. It Has Never Done That Before.
The Harvard Law School Forum on Corporate Governance
·
ከ17 ሰዓቶች በፊት
Board Practices and Composition in the Russell 3000 and S&P 500
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com